Drug
Aripiprazole lauroxil clinical trials
Also written ARISTADA.
A product of Aripiprazole; its studies count on that page too.
- studies test it
- 10
- open now
- 0
- in phase 3
- 4
- first study started
- 2011
How studies write it
Studies that test it under each name
Brand
Development codes
Studies by the year they started
10 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 3
- 4
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 2
Alkermes, Inc. (8) · University of Miami (1) · University of California, Los Angeles (1)
Studies
Open first, then newest update. How each study uses aripiprazole lauroxil is read from its arms, and is right about nine times in ten.
Testing it · 10
- C-Cog in Early Course Schizophrenia StudyTerminatedPhase 4University of MiamiNCT05662306Written as Aripiprazole Lauroxil
- Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia EpisodeTerminatedPhase 4University of California, Los AngelesNCT04203056Written as Aripiprazole Lauroxil
- A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of SchizophreniaCompletedPhase 3Alkermes, Inc.NCT03345979Written as Aripiprazole Lauroxil
- A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With SchizophreniaCompletedPhase 3Alkermes, Inc.NCT01469039Written as ALKS 9072
- A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With SchizophreniaCompletedPhase 4Alkermes, Inc.NCT02634320Written as Aripiprazole Lauroxil
- A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)CompletedPhase 3Alkermes, Inc.NCT01626456Written as ALKS 9072, Low
- A Study of ALKS 9072 in Subjects With Chronic Stable SchizophreniaCompletedPhase 1Alkermes, Inc.NCT01493726Written as ALKS 9072, Low dose
- An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaCompletedPhase 1Alkermes, Inc.NCT02320032Written as Aripiprazole Lauroxil
- An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)CompletedPhase 3Alkermes, Inc.NCT01895452Written as ALKS 9072, Low Dose
- A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective DisorderCompletedPhase 1Alkermes, Inc.NCT02636842Written as Aripiprazole Lauroxil
Codes
What other systems call aripiprazole lauroxil · ClinicalTrials.gg INT000363
- MeSH (NLM) C000603935aripiprazole lauroxilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) B786J7A343ARIPIPRAZOLE LAUROXILConfirmed FDA, NLM, Wikidata
- RxNorm 1673265Confirmed FDA, Wikidata
- Wikidata Q25323757aripiprazole lauroxilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C142931Aripiprazole LauroxilOne source FDA
- DrugBank DB14185One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000603935 | aripiprazole lauroxil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | B786J7A343 | ARIPIPRAZOLE LAUROXIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1673265 | — | Confirmed FDA, Wikidata |
| Wikidata | Q25323757 | aripiprazole lauroxil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C142931 | Aripiprazole Lauroxil | One source FDA |
| DrugBank | DB14185 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.